Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 20 October, 2025
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 507815 | NSE: GILLETTE

Gillette India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 20, 2025, 4:45 pm

Market Cap 30,338 Cr.
Current Price 9,306
High / Low 11,505/7,412
Stock P/E53.8
Book Value 314
Dividend Yield1.20 %
ROCE56.1 %
ROE41.6 %
Face Value 10.0
PEG Ratio3.77

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Gillette India Ltd

Competitors of Gillette India Ltd

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Honasa Consumer Ltd 8,972 Cr. 276 427/190126 36.90.00 %7.44 %5.51 % 10.0
Ambica Agarbathies Aroma & Industries Ltd 43.3 Cr. 25.2 37.0/24.084.9 63.60.00 %7.49 %0.45 % 10.0
Ador Multi Products Ltd 76.5 Cr. 80.0 119/23.4 19.40.00 %11.4 %3.09 % 10.0
Kaya Ltd 679 Cr. 447 488/204 1060.00 %2.50 %% 10.0
Jyothy Labs Ltd 11,624 Cr. 317 545/26831.8 55.81.11 %24.6 %19.0 % 1.00
Industry Average74,546.43 Cr2,056.0661.71107.490.71%29.21%23.91%4.94

All Competitor Stocks of Gillette India Ltd

Quarterly Result

MetricJun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Sales 553620619619619668639681645782686767707
Expenses 441484493485476530483519470591503542496
Operating Profit 112136126134144138157161176190183226210
OPM % 20%22%20%22%23%21%25%24%27%24%27%29%30%
Other Income 233125976579127
Interest 2031314441431
Depreciation 19181922222021212119212520
Profit before tax 92120106123124125139143155177167210195
Tax % 27%28%30%16%26%26%25%31%25%25%25%24%25%
Net Profit 688774103929310499116133126159146
EPS in Rs 20.7426.6322.8531.5228.1628.4531.9030.4135.5940.8238.6648.7044.71

Last Updated: August 2, 2025, 1:15 am

Below is a detailed analysis of the quarterly data for Gillette India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

  • For Sales, as of Jun 2025, the value is 707.00 Cr.. The value appears to be declining and may need further review. It has decreased from 767.00 Cr. (Mar 2025) to 707.00 Cr., marking a decrease of 60.00 Cr..
  • For Expenses, as of Jun 2025, the value is 496.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 542.00 Cr. (Mar 2025) to 496.00 Cr., marking a decrease of 46.00 Cr..
  • For Operating Profit, as of Jun 2025, the value is 210.00 Cr.. The value appears to be declining and may need further review. It has decreased from 226.00 Cr. (Mar 2025) to 210.00 Cr., marking a decrease of 16.00 Cr..
  • For OPM %, as of Jun 2025, the value is 30.00%. The value appears strong and on an upward trend. It has increased from 29.00% (Mar 2025) to 30.00%, marking an increase of 1.00%.
  • For Other Income, as of Jun 2025, the value is 7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2025) to 7.00 Cr., marking a decrease of 5.00 Cr..
  • For Interest, as of Jun 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 2.00 Cr..
  • For Depreciation, as of Jun 2025, the value is 20.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 25.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 5.00 Cr..
  • For Profit before tax, as of Jun 2025, the value is 195.00 Cr.. The value appears to be declining and may need further review. It has decreased from 210.00 Cr. (Mar 2025) to 195.00 Cr., marking a decrease of 15.00 Cr..
  • For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 25.00%, marking an increase of 1.00%.
  • For Net Profit, as of Jun 2025, the value is 146.00 Cr.. The value appears to be declining and may need further review. It has decreased from 159.00 Cr. (Mar 2025) to 146.00 Cr., marking a decrease of 13.00 Cr..
  • For EPS in Rs, as of Jun 2025, the value is 44.71. The value appears to be declining and may need further review. It has decreased from 48.70 (Mar 2025) to 44.71, marking a decrease of 3.99.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 4:15 pm

MetricJun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025n n 9mTTM
Sales 1,6621,8751,7551,7331,6771,8621,6791,9822,2562,4772,6332,2352,942
Expenses 1,5891,6841,4481,3481,2901,4781,3191,5221,7731,9371,9951,6352,132
Operating Profit 73191306385387384360460483540638600809
OPM % 4%10%17%22%23%21%21%23%21%22%24%27%28%
Other Income 386850348111132722202735
Interest 0567785511813910
Depreciation 33393038424851586881836485
Profit before tax 78215320374345339314429411473562554750
Tax % 34%26%33%32%34%25%27%28%30%25%27%25%
Net Profit 51158214253229253230310289356412418563
EPS in Rs 15.7848.5365.7377.6770.2977.6270.6495.2588.79109.15126.35128.17172.89
Dividend Payout % 95%31%60%211%33%57%69%125%78%78%103%87%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year
YoY Net Profit Growth (%)
Change in YoY Net Profit Growth (%)

No data available for trend analysis.

Growth

Compounded Sales Growth
10 Years:3%
5 Years:4%
3 Years:4%
TTM:12%
Compounded Profit Growth
10 Years:23%
5 Years:10%
3 Years:11%
TTM:37%
Stock Price CAGR
10 Years:9%
5 Years:14%
3 Years:25%
1 Year:17%
Return on Equity
10 Years:34%
5 Years:36%
3 Years:39%
Last Year:42%

Last Updated: September 4, 2025, 9:25 pm

Balance Sheet

Last Updated: September 10, 2025, 1:30 pm

MonthJun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025
Equity Capital 333333333333333333333333
Reserves 611710904468662746879756829956939991
Borrowings 000000000000
Other Liabilities 411468488498515432441606758927859895
Total Liabilities 1,0541,2101,4249981,2091,2101,3521,3951,6191,9161,8311,918
Fixed Assets 173156178214264300296310363389347342
CWIP 616388634025217265322617
Investments 000000000000
Other Assets 8219911,1587219048861,0341,0131,1911,4941,4581,558
Total Assets 1,0541,2101,4249981,2091,2101,3521,3951,6191,9161,8311,918

Below is a detailed analysis of the balance sheet data for Gillette India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Mar 2025, the value is 33.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2024) which recorded 33.00 Cr..
  • For Reserves, as of Mar 2025, the value is 991.00 Cr.. The value appears strong and on an upward trend. It has increased from 939.00 Cr. (Jun 2024) to 991.00 Cr., marking an increase of 52.00 Cr..
  • For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Jun 2024) which recorded 0.00 Cr..
  • For Other Liabilities, as of Mar 2025, the value is 895.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 859.00 Cr. (Jun 2024) to 895.00 Cr., marking an increase of 36.00 Cr..
  • For Total Liabilities, as of Mar 2025, the value is 1,918.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,831.00 Cr. (Jun 2024) to 1,918.00 Cr., marking an increase of 87.00 Cr..
  • For Fixed Assets, as of Mar 2025, the value is 342.00 Cr.. The value appears to be declining and may need further review. It has decreased from 347.00 Cr. (Jun 2024) to 342.00 Cr., marking a decrease of 5.00 Cr..
  • For CWIP, as of Mar 2025, the value is 17.00 Cr.. The value appears to be declining and may need further review. It has decreased from 26.00 Cr. (Jun 2024) to 17.00 Cr., marking a decrease of 9.00 Cr..
  • For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2024) which recorded 0.00 Cr..
  • For Other Assets, as of Mar 2025, the value is 1,558.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,458.00 Cr. (Jun 2024) to 1,558.00 Cr., marking an increase of 100.00 Cr..
  • For Total Assets, as of Mar 2025, the value is 1,918.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,831.00 Cr. (Jun 2024) to 1,918.00 Cr., marking an increase of 87.00 Cr..

Notably, the Reserves (991.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow - No data available for this post.

Free Cash Flow

MonthJun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025n n 9m
Free Cash Flow73.00191.00306.00385.00387.00384.00360.00460.00483.00540.00638.00600.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthJun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025
Debtor Days202323273836413643473862
Inventory Days10487104103105104136152130127131181
Days Payable116116137150173126138169193209212260
Cash Conversion Cycle9-6-10-19-30154019-20-35-43-17
Working Capital Days2749-10-17-18153514-0-4-713
ROCE %12%35%39%54%60%48%38%51%51%52%59%56%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Promoters75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%
FIIs2.34%2.50%1.52%0.66%0.61%0.64%0.71%1.84%3.27%4.11%4.33%4.82%
DIIs10.37%10.16%10.78%11.29%11.08%11.22%12.82%12.08%10.79%9.95%9.89%9.60%
Government0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.01%0.01%
Public12.31%12.35%12.71%13.06%13.32%13.15%11.48%11.08%10.96%10.94%10.78%10.58%
No. of Shareholders47,76247,61548,18950,90650,83649,67551,11847,72150,73051,39652,13449,531

Shareholding Pattern Chart

No. of Shareholders

Gillette India Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Aditya Birla Sun Life ELSS Tax Saver Fund 464,089 2.04 305.64464,0892025-04-22 17:25:440%
Aditya Birla Sun Life MNC Fund - Div 194,572 3.57 128.14194,5722025-04-22 17:25:440%
Aditya Birla Sun Life MNC Fund - Gr 194,572 3.57 128.14194,5722025-04-22 17:25:440%
Nippon India Multi Cap Fund 190,000 0.49 125.13190,0002025-04-22 17:25:450%
Nippon India Large Cap Fund 165,000 0.51 108.67165,0002025-04-22 13:03:420%
ICICI Prudential India Opportunities Fund 127,095 0.52 83.7127,0952025-04-22 17:25:450%
ICICI Prudential Smallcap Fund 117,482 1.04 77.37117,4822025-04-22 17:25:450%
ICICI Prudential FMCG Fund - Dividend 100,459 4.44 66.16100,4592025-04-22 17:25:450%
ICICI Prudential FMCG Fund - Growth 100,459 4.44 66.16100,4592025-04-22 17:25:450%
ICICI Prudential Bharat Consumption Fund 94,494 2.82 62.2394,4942025-04-22 17:25:450%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Jun 24Jun 23Jun 22Jun 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 128.17126.35109.1588.7995.25
Diluted EPS (Rs.) 128.17126.35109.1588.7995.25
Cash EPS (Rs.) 147.88151.68133.90109.75112.89
Book Value[Excl.RevalReserv]/Share (Rs.) 313.93298.03303.42264.25242.10
Book Value[Incl.RevalReserv]/Share (Rs.) 313.93298.03303.42264.25242.10
Dividend / Share (Rs.) 112.00130.0085.0069.00119.00
Revenue From Operations / Share (Rs.) 685.74807.94760.06692.28616.58
PBDIT / Share (Rs.) 192.37200.53172.25150.42151.04
PBIT / Share (Rs.) 172.65175.17147.49129.44133.39
PBT / Share (Rs.) 170.04172.52145.10126.21131.78
Net Profit / Share (Rs.) 128.16126.33109.1488.7895.24
PBDIT Margin (%) 28.0524.8122.6621.7224.49
PBIT Margin (%) 25.1721.6819.4018.6921.63
PBT Margin (%) 24.7921.3519.0918.2321.37
Net Profit Margin (%) 18.6815.6314.3512.8215.44
Return on Networth / Equity (%) 40.8242.3835.9633.5939.33
Return on Capital Employeed (%) 49.5353.2643.6844.6650.06
Return On Assets (%) 21.7722.4818.5617.9822.24
Asset Turnover Ratio (%) 1.191.411.411.501.46
Current Ratio (X) 1.641.561.531.431.46
Quick Ratio (X) 1.061.041.030.870.76
Inventory Turnover Ratio (X) 5.266.521.731.601.48
Dividend Payout Ratio (NP) (%) 85.81106.8465.0477.71138.57
Dividend Payout Ratio (CP) (%) 74.3788.9853.0162.85116.91
Earning Retention Ratio (%) 14.19-6.8434.9622.29-38.57
Cash Earning Retention Ratio (%) 25.6311.0246.9937.15-16.91
Interest Coverage Ratio (X) 73.6775.7372.2546.5593.76
Interest Coverage Ratio (Post Tax) (X) 50.0848.7146.7828.4860.12
Enterprise Value (Cr.) 25719.1823131.9116107.6616033.2618343.17
EV / Net Operating Revenue (X) 11.518.796.507.119.13
EV / EBITDA (X) 41.0235.4028.6932.7137.27
MarketCap / Net Operating Revenue (X) 11.708.976.697.249.21
Retention Ratios (%) 14.18-6.8434.9522.28-38.57
Price / BV (X) 25.5524.3116.7518.9623.46
Price / Net Operating Revenue (X) 11.708.976.697.249.21
EarningsYield 0.010.010.020.010.01

After reviewing the key financial ratios for Gillette India Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Jun 24) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 128.17. This value is within the healthy range. It has increased from 126.35 (Jun 24) to 128.17, marking an increase of 1.82.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 128.17. This value is within the healthy range. It has increased from 126.35 (Jun 24) to 128.17, marking an increase of 1.82.
  • For Cash EPS (Rs.), as of Mar 25, the value is 147.88. This value is within the healthy range. It has decreased from 151.68 (Jun 24) to 147.88, marking a decrease of 3.80.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 313.93. It has increased from 298.03 (Jun 24) to 313.93, marking an increase of 15.90.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 313.93. It has increased from 298.03 (Jun 24) to 313.93, marking an increase of 15.90.
  • For Dividend / Share (Rs.), as of Mar 25, the value is 112.00. This value exceeds the healthy maximum of 3. It has decreased from 130.00 (Jun 24) to 112.00, marking a decrease of 18.00.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 685.74. It has decreased from 807.94 (Jun 24) to 685.74, marking a decrease of 122.20.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 192.37. This value is within the healthy range. It has decreased from 200.53 (Jun 24) to 192.37, marking a decrease of 8.16.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 172.65. This value is within the healthy range. It has decreased from 175.17 (Jun 24) to 172.65, marking a decrease of 2.52.
  • For PBT / Share (Rs.), as of Mar 25, the value is 170.04. This value is within the healthy range. It has decreased from 172.52 (Jun 24) to 170.04, marking a decrease of 2.48.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 128.16. This value is within the healthy range. It has increased from 126.33 (Jun 24) to 128.16, marking an increase of 1.83.
  • For PBDIT Margin (%), as of Mar 25, the value is 28.05. This value is within the healthy range. It has increased from 24.81 (Jun 24) to 28.05, marking an increase of 3.24.
  • For PBIT Margin (%), as of Mar 25, the value is 25.17. This value exceeds the healthy maximum of 20. It has increased from 21.68 (Jun 24) to 25.17, marking an increase of 3.49.
  • For PBT Margin (%), as of Mar 25, the value is 24.79. This value is within the healthy range. It has increased from 21.35 (Jun 24) to 24.79, marking an increase of 3.44.
  • For Net Profit Margin (%), as of Mar 25, the value is 18.68. This value exceeds the healthy maximum of 10. It has increased from 15.63 (Jun 24) to 18.68, marking an increase of 3.05.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 40.82. This value is within the healthy range. It has decreased from 42.38 (Jun 24) to 40.82, marking a decrease of 1.56.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 49.53. This value is within the healthy range. It has decreased from 53.26 (Jun 24) to 49.53, marking a decrease of 3.73.
  • For Return On Assets (%), as of Mar 25, the value is 21.77. This value is within the healthy range. It has decreased from 22.48 (Jun 24) to 21.77, marking a decrease of 0.71.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 1.19. It has decreased from 1.41 (Jun 24) to 1.19, marking a decrease of 0.22.
  • For Current Ratio (X), as of Mar 25, the value is 1.64. This value is within the healthy range. It has increased from 1.56 (Jun 24) to 1.64, marking an increase of 0.08.
  • For Quick Ratio (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has increased from 1.04 (Jun 24) to 1.06, marking an increase of 0.02.
  • For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.26. This value is within the healthy range. It has decreased from 6.52 (Jun 24) to 5.26, marking a decrease of 1.26.
  • For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 85.81. This value exceeds the healthy maximum of 50. It has decreased from 106.84 (Jun 24) to 85.81, marking a decrease of 21.03.
  • For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 74.37. This value exceeds the healthy maximum of 50. It has decreased from 88.98 (Jun 24) to 74.37, marking a decrease of 14.61.
  • For Earning Retention Ratio (%), as of Mar 25, the value is 14.19. This value is below the healthy minimum of 40. It has increased from -6.84 (Jun 24) to 14.19, marking an increase of 21.03.
  • For Cash Earning Retention Ratio (%), as of Mar 25, the value is 25.63. This value is below the healthy minimum of 40. It has increased from 11.02 (Jun 24) to 25.63, marking an increase of 14.61.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 73.67. This value is within the healthy range. It has decreased from 75.73 (Jun 24) to 73.67, marking a decrease of 2.06.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 50.08. This value is within the healthy range. It has increased from 48.71 (Jun 24) to 50.08, marking an increase of 1.37.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 25,719.18. It has increased from 23,131.91 (Jun 24) to 25,719.18, marking an increase of 2,587.27.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 11.51. This value exceeds the healthy maximum of 3. It has increased from 8.79 (Jun 24) to 11.51, marking an increase of 2.72.
  • For EV / EBITDA (X), as of Mar 25, the value is 41.02. This value exceeds the healthy maximum of 15. It has increased from 35.40 (Jun 24) to 41.02, marking an increase of 5.62.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 11.70. This value exceeds the healthy maximum of 3. It has increased from 8.97 (Jun 24) to 11.70, marking an increase of 2.73.
  • For Retention Ratios (%), as of Mar 25, the value is 14.18. This value is below the healthy minimum of 30. It has increased from -6.84 (Jun 24) to 14.18, marking an increase of 21.02.
  • For Price / BV (X), as of Mar 25, the value is 25.55. This value exceeds the healthy maximum of 3. It has increased from 24.31 (Jun 24) to 25.55, marking an increase of 1.24.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 11.70. This value exceeds the healthy maximum of 3. It has increased from 8.97 (Jun 24) to 11.70, marking an increase of 2.73.
  • For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Jun 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Gillette India Ltd as of October 20, 2025 is: 5,689.52

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of October 20, 2025, Gillette India Ltd is Overvalued by 38.86% compared to the current share price 9,306.00

Intrinsic Value of Gillette India Ltd as of October 20, 2025 is: 6,500.65

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of October 20, 2025, Gillette India Ltd is Overvalued by 30.15% compared to the current share price 9,306.00

Last 5 Year EPS CAGR: 14.26%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 46.25%, which is a positive sign.
  2. The stock has a low average Working Capital Days of 8.08, which is a positive sign.
  3. The stock has a low average Cash Conversion Cycle of -8.08, which is a positive sign.
  4. The company has higher reserves (787.58 cr) compared to borrowings (0.00 cr), indicating strong financial stability.
  5. The company has shown consistent growth in sales (1.38 cr) and profit (397.23 cr) over the years.

    Stock Analysis

    • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gillette India Ltd:
      1. Net Profit Margin: 18.68%
        • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
      2. ROCE: 49.53% (Industry Average ROCE: 29.21%)
        • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
      3. ROE%: 40.82% (Industry Average ROE: 22.42%)
        • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
      4. Interest Coverage Ratio (Post Tax): 50.08
        • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
      5. Quick Ratio: 1.06
        • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
      6. Stock P/E: 53.8 (Industry average Stock P/E: 50.14)
        • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
      7. Total Debt / Equity: 0
        • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
      The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
      Stock Rating:

    About the Company - Qualitative Analysis

    Gillette India Ltd. is a Public Limited Listed company incorporated on 09/02/1984 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L28931MH1984PLC267130 and registration number is 267130. Currently Company is involved in the business activities of Manufacture of cosmetics and toileteries (includes manufacture of pre- shave, shaving or after shave preparations; personal deodorants and anti- respirants; perfumed bath salts and other bath preparations; beauty or make-up preparations and preparations for the care of the skin, other than medicaments; manicure and pedicure preparations etc.). Company's Total Operating Revenue is Rs. 2234.84 Cr. and Equity Capital is Rs. 32.59 Cr. for the Year ended 31/03/2025.
    INDUSTRYADDRESSCONTACT
    Personal CareP&G Plaza, Cardinal Gracias Road, Mumbai Maharashtra 400099investorgil.im@pg.com
    https://www.gillette.co.in
    Management
    NamePosition Held
    Ms. Anjuly Chib DuggalChairperson & Independent Director
    Mr. Kumar VenkatasubramanianManaging Director
    Ms. Srividya SrinivasanExecutive Director & CFO
    Mr. Srinivas Maruthi PatnamExecutive Director
    Mr. Pramod AgarwalNon Executive Director
    Mr. Sanjay AsherIndependent Director
    Mr. C P GurnaniIndependent Director

    FAQ

    What is the intrinsic value of Gillette India Ltd?

    Gillette India Ltd's intrinsic value (as of 20 October 2025) is 5689.52 which is 38.86% lower the current market price of 9,306.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 30,338 Cr. market cap, FY2025-2026 high/low of 11,505/7,412, reserves of ₹991 Cr, and liabilities of 1,918 Cr.

    What is the Market Cap of Gillette India Ltd?

    The Market Cap of Gillette India Ltd is 30,338 Cr..

    What is the current Stock Price of Gillette India Ltd as on 20 October 2025?

    The current stock price of Gillette India Ltd as on 20 October 2025 is 9,306.

    What is the High / Low of Gillette India Ltd stocks in FY 2025-2026?

    In FY 2025-2026, the High / Low of Gillette India Ltd stocks is 11,505/7,412.

    What is the Stock P/E of Gillette India Ltd?

    The Stock P/E of Gillette India Ltd is 53.8.

    What is the Book Value of Gillette India Ltd?

    The Book Value of Gillette India Ltd is 314.

    What is the Dividend Yield of Gillette India Ltd?

    The Dividend Yield of Gillette India Ltd is 1.20 %.

    What is the ROCE of Gillette India Ltd?

    The ROCE of Gillette India Ltd is 56.1 %.

    What is the ROE of Gillette India Ltd?

    The ROE of Gillette India Ltd is 41.6 %.

    What is the Face Value of Gillette India Ltd?

    The Face Value of Gillette India Ltd is 10.0.

    Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Gillette India Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE